As of 2025-08-06, the Relative Valuation of Novartis AG (NOVN.SW) is 105.24 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 95.47 CHF, the upside of Novartis AG based on Relative Valuation is 10.2%.
The range of the Relative Valuation is 92.18 - 130.35 CHF.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 25.1x | 22.1x |
| Forward P/E multiples | 19.3x - 21.0x | 20.0x |
| Fair Price | 92.18 - 130.35 | 105.24 |
| Upside | -3.4% - 36.5% | 10.2% |
| Date | P/E |
| 2025-08-04 | 18.20 |
| 2025-07-31 | 18.12 |
| 2025-07-30 | 18.28 |
| 2025-07-29 | 18.22 |
| 2025-07-28 | 17.96 |
| 2025-07-25 | 17.86 |
| 2025-07-24 | 18.00 |
| 2025-07-23 | 17.92 |
| 2025-07-22 | 17.73 |
| 2025-07-21 | 17.61 |
| 2025-07-18 | 17.76 |
| 2025-07-17 | 17.96 |
| 2025-07-16 | 18.30 |
| 2025-07-15 | 18.48 |
| 2025-07-14 | 18.55 |
| 2025-07-11 | 18.51 |
| 2025-07-10 | 19.09 |
| 2025-07-09 | 18.77 |
| 2025-07-08 | 18.80 |
| 2025-07-07 | 18.78 |
| 2025-07-04 | 18.88 |
| 2025-07-03 | 18.62 |
| 2025-07-02 | 18.94 |
| 2025-07-01 | 18.84 |
| 2025-06-30 | 18.50 |
| 2025-06-27 | 18.51 |
| 2025-06-26 | 18.47 |
| 2025-06-25 | 18.28 |
| 2025-06-24 | 18.36 |
| 2025-06-23 | 18.29 |
| 2025-06-20 | 18.26 |
| 2025-06-19 | 18.32 |
| 2025-06-18 | 18.27 |
| 2025-06-17 | 18.39 |
| 2025-06-16 | 18.54 |
| 2025-06-13 | 18.69 |
| 2025-06-12 | 18.87 |
| 2025-06-11 | 18.66 |
| 2025-06-10 | 18.77 |
| 2025-06-05 | 18.60 |
| 2025-06-04 | 18.48 |
| 2025-06-03 | 18.34 |
| 2025-06-02 | 18.29 |
| 2025-05-30 | 18.09 |
| 2025-05-28 | 17.84 |
| 2025-05-27 | 18.02 |
| 2025-05-26 | 18.05 |
| 2025-05-23 | 17.85 |
| 2025-05-22 | 17.89 |
| 2025-05-21 | 18.04 |